JPMorgan Chase & Co’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72K | Sell |
192
-934
| -83% | -$8.37K | ﹤0.01% | 5670 |
|
|
2025
Q1 | $7.11K | Sell |
1,126
-2,003
| -64% | -$12.6K | ﹤0.01% | 5506 |
|
|
2024
Q4 | $32.3K | Buy |
3,129
+1,934
| +162% | +$20K | ﹤0.01% | 5123 |
|
|
2024
Q3 | $15.4K | Buy |
1,195
+782
| +189% | +$10.1K | ﹤0.01% | 5248 |
|
|
2024
Q2 | $5.72K | Sell |
413
-1,775
| -81% | -$24.6K | ﹤0.01% | 5349 |
|
|
2024
Q1 | $680K | Buy |
2,188
+1,525
| +230% | +$474K | ﹤0.01% | 3788 |
|
|
2023
Q4 | $174K | Buy |
663
+662
| +66,200% | +$174K | ﹤0.01% | 4519 |
|
|
2023
Q3 | $133 | Hold |
1
| – | – | ﹤0.01% | 5926 |
|
|
2023
Q2 | $140 | Hold |
1
| – | – | ﹤0.01% | 5764 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5999 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5784 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5697 |
|
|
2022
Q2 | $0 | Sell |
1
-154
| -99% | – | ﹤0.01% | 5767 |
|
|
2022
Q1 | $31K | Buy |
155
+138
| +812% | +$27.6K | ﹤0.01% | 5161 |
|
|
2021
Q4 | $4K | Buy |
17
+16
| +1,600% | +$3.77K | ﹤0.01% | 5533 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5651 |
|
|
2021
Q2 | $0 | Sell |
1
-2,947
| -100% | – | ﹤0.01% | 5571 |
|
|
2021
Q1 | $1.71M | Sell |
2,948
-872
| -23% | -$506K | ﹤0.01% | 3331 |
|
|
2020
Q4 | $2.18M | Buy |
3,820
+3,782
| +9,953% | +$2.16M | ﹤0.01% | 2916 |
|
|
2020
Q3 | $22K | Sell |
38
-29
| -43% | -$16.8K | ﹤0.01% | 4467 |
|
|
2020
Q2 | $38K | Buy |
+67
| New | +$38K | ﹤0.01% | 4293 |
|